ICU Medical, Inc. develops, manufactures, and sells innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
Current Value
$169.011 Year Return
Current Value
$169.011 Year Return
Market Cap
$4.15B
P/E Ratio
-37.16
1Y Stock Return
104.38%
1Y Revenue Growth
3.99%
Dividend Yield
0.00%
Price to Book
2.0
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HCAT | 58.94% | $458.79M | 0.00% | 0.00% |
NOVT | 56.58% | $5.95B | +15.14% | 0.00% |
XPEL | 53.24% | $1.18B | -7.73% | 0.00% |
XMTR | 52.11% | $1.48B | +50.13% | 0.00% |
SPB | 51.85% | $2.53B | +37.09% | 1.89% |
UA | 51.62% | $3.71B | +18.70% | 0.00% |
PDM | 51.41% | $1.17B | +53.51% | 5.34% |
ECPG | 50.64% | $1.15B | +10.73% | 0.00% |
OLO | 50.57% | $1.06B | +30.00% | 0.00% |
ZG | 50.43% | $16.94B | +95.87% | 0.00% |
ACVA | 50.33% | $3.60B | +39.71% | 0.00% |
UE | 50.28% | $2.93B | +40.88% | 2.86% |
DGII | 50.07% | $1.14B | +27.53% | 0.00% |
KN | 50.06% | $1.60B | +12.19% | 0.00% |
TXG | 50.06% | $1.64B | -68.30% | 0.00% |
Z | 49.89% | $17.58B | +96.27% | 0.00% |
YETI | 49.25% | $3.22B | -10.71% | 0.00% |
AXGN | 49.25% | $561.11M | +113.93% | 0.00% |
APPS | 49.17% | $125.51M | -75.85% | 0.00% |
AVNT | 48.90% | $4.56B | +44.78% | 2.08% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | 0.02% | $35.48M | -75.45% | 0.00% |
SRRK | -0.06% | $2.61B | +134.91% | 0.00% |
OCX | 0.12% | $42.93M | -36.09% | 0.00% |
VHC | -0.36% | $19.06M | -38.36% | 0.00% |
CCEC | -0.39% | $1.02B | +28.03% | 3.26% |
AJG | 0.39% | $64.17B | +17.51% | 0.80% |
NNVC | 0.40% | $19.66M | +25.69% | 0.00% |
ALTG | 0.45% | $236.78M | -29.08% | 3.22% |
CORZ | -0.50% | $4.60B | +3,201.26% | 0.00% |
EG | 0.57% | $15.92B | -8.98% | 2.02% |
RNR | -0.61% | $13.74B | +23.09% | 0.58% |
CYD | -0.65% | $364.46M | -2.94% | 4.26% |
MSDL | 0.69% | $1.83B | +0.66% | 7.26% |
GDRX | -0.70% | $1.62B | -24.15% | 0.00% |
TRVG | 0.70% | $37.05M | -37.92% | 0.00% |
FSLY | 0.76% | $941.41M | -61.50% | 0.00% |
TLPH | 0.80% | $11.41M | +9.85% | 0.00% |
SRPT | -0.80% | $10.18B | +26.81% | 0.00% |
CPSH | 0.81% | $20.70M | -40.13% | 0.00% |
DELL | 0.85% | $99.00B | +84.60% | 1.24% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MCK | -27.81% | $78.15B | +35.51% | 0.42% |
RLMD | -14.89% | $89.92M | +1.36% | 0.00% |
CDLX | -14.68% | $178.39M | -54.00% | 0.00% |
HUSA | -13.43% | $16.69M | -11.56% | 0.00% |
BROS | -11.01% | $5.67B | +74.77% | 0.00% |
PGR | -10.69% | $149.10B | +57.29% | 0.45% |
MNST | -10.21% | $52.25B | -1.95% | 0.00% |
BMBL | -9.41% | $845.98M | -43.90% | 0.00% |
FROG | -9.39% | $3.34B | +11.67% | 0.00% |
RAMP | -7.52% | $1.86B | -16.17% | 0.00% |
MNR | -7.36% | $1.66B | -10.71% | 15.90% |
TPST | -7.25% | $37.75M | -77.59% | 0.00% |
IRWD | -6.68% | $609.71M | -59.34% | 0.00% |
KRRO | -6.46% | $436.84M | +20.68% | 0.00% |
QTTB | -6.18% | $354.34M | +188.64% | 0.00% |
FATBB | -5.32% | $81.94M | -12.91% | 11.69% |
CBOE | -5.11% | $21.46B | +15.84% | 1.11% |
PULM | -5.00% | $19.83M | +202.98% | 0.00% |
OXBR | -4.98% | $19.05M | +178.18% | 0.00% |
COR | -4.96% | $47.48B | +21.20% | 0.86% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XHE | 61.05% | $213.41M | 0.35% |
SPSM | 57.25% | $12.72B | 0.03% |
VIOV | 57.10% | $1.44B | 0.15% |
SMMD | 57.01% | $1.24B | 0.15% |
NUSC | 56.97% | $1.27B | 0.31% |
IJR | 56.86% | $90.05B | 0.06% |
IWR | 56.82% | $39.67B | 0.19% |
ESML | 56.77% | $1.90B | 0.17% |
VIOO | 56.63% | $3.12B | 0.1% |
FLQM | 56.61% | $1.25B | 0.3% |
SLYV | 56.59% | $4.16B | 0.15% |
MDYV | 56.56% | $3.25B | 0.15% |
IJS | 56.55% | $7.37B | 0.18% |
VB | 56.48% | $63.63B | 0.05% |
SMOT | 56.44% | $374.04M | 0.49% |
SCHV | 56.42% | $12.04B | 0.04% |
IWS | 56.33% | $13.85B | 0.23% |
PY | 56.33% | $78.15M | 0.15% |
VO | 56.31% | $73.70B | 0.04% |
FMAT | 56.24% | $556.09M | 0.084% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
HDRO | -0.79% | $164.26M | 0.3% |
MINT | -0.80% | $11.62B | 0.35% |
AGZD | -1.84% | $142.76M | 0.23% |
IBTE | -1.85% | $1.70B | 0.07% |
DBA | -2.01% | $755.88M | 0.93% |
ICLO | 2.28% | $209.30M | 0.2% |
TPMN | -2.28% | $40.60M | 0.65% |
CGSM | 2.31% | $514.53M | 0.25% |
FMF | 2.34% | $244.61M | 0.95% |
BOXX | 2.38% | $4.43B | 0.1949% |
KRBN | 3.24% | $242.47M | 0.85% |
MUST | 3.84% | $410.00M | 0.23% |
WEAT | -3.86% | $120.27M | 0.28% |
BSCO | -4.01% | $2.35B | 0.1% |
IBHD | 4.10% | $327.80M | 0.35% |
XHLF | 4.44% | $874.27M | 0.03% |
XBIL | 4.52% | $637.70M | 0.15% |
PWZ | 4.58% | $697.36M | 0.28% |
TBIL | 4.64% | $4.38B | 0.15% |
DFNM | 4.66% | $1.40B | 0.17% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -44.66% | $388.04M | 1.43% |
VIXY | -29.98% | $195.31M | 0.85% |
USDU | -23.98% | $201.97M | 0.5% |
TAIL | -21.18% | $67.98M | 0.59% |
UUP | -18.78% | $309.25M | 0.77% |
HIGH | -15.80% | $302.78M | 0.51% |
EQLS | -14.02% | $76.08M | 1% |
CTA | -13.25% | $350.27M | 0.78% |
SOYB | -11.34% | $27.32M | 0.22% |
KMLM | -9.79% | $353.87M | 0.9% |
CLOI | -9.15% | $715.40M | 0.4% |
KCCA | -7.84% | $220.51M | 0.87% |
CORN | -5.42% | $61.12M | 0.2% |
BSCO | -4.01% | $2.35B | 0.1% |
WEAT | -3.86% | $120.27M | 0.28% |
TPMN | -2.28% | $40.60M | 0.65% |
DBA | -2.01% | $755.88M | 0.93% |
IBTE | -1.85% | $1.70B | 0.07% |
AGZD | -1.84% | $142.76M | 0.23% |
MINT | -0.80% | $11.62B | 0.35% |
Yahoo
Shareholders might have noticed that ICU Medical, Inc. ( NASDAQ:ICUI ) filed its third-quarter result this time last...
Yahoo
ICU Medical ( NASDAQ:ICUI ) Third Quarter 2024 Results Key Financial Results Revenue: US$589.1m (up 6.5% from 3Q 2023...
Finnhub
UBS Global Healthcare Conference November 13, 2024 Disclosures Any statement concerning...
Yahoo
ICU Medical Inc (ICUI) reports robust financial performance with a 7% revenue increase and raises full-year guidance, while unveiling a strategic partnership with Otsuka Pharmaceutical.
Finnhub
ICU Medical, Inc Q3 2024 Conference Call Presentation November 12, 2024 Disclosures ...
Yahoo
ICU Medical (ICUI) delivered earnings and revenue surprises of 27.20% and 0.92%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.